Sign in
4

Changes in Ownership

Editas Medicine, Inc. Filed Acc 0001650664-25-000141

CEO sold 5,592 shares at $2.60 ($14,517)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
O'Neill Gilmore Neil CEO 2025-09-03 Sale 10b5-1 −5,592 $2.60 $14,517 274,690 D: show line 1 in the form
Open-market sales · 5,592 sh · avg $2.60 · $14,517
Loading xslF345X05/wk-form4_1757017197.xml…